The hands in health and disease of individuals with filaggrin loss-of-function mutations: Clinical reflections on the hand eczema phenotype

Contact Dermatitis

Volumn 67, Issue 3, 2012, Pages 119-124

  Kaae, Jeanette ^a   Menné, Torkil ^a   Carlsen, Berit C ^a   Zachariae, Claus ^a   Thyssen, Jacob P ^a  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

classification; filaggrin; hand eczema; loss of function mutations; phenotype

Indexed keywords

FILAGGRIN;

HAND ECZEMA; HUMAN; HYPERKERATOSIS; LOSS OF FUNCTION MUTATION; PHENOTYPE; REVIEW; SKIN FISSURE; XEROSIS;

ADULT; CHILD; ECZEMA; FEMALE; HAND DERMATOSES; HETEROZYGOTE; HUMANS; INTERMEDIATE FILAMENT PROTEINS; MALE; MIDDLE AGED; MUTATION; PHENOTYPE;

EID: 84865274816     PISSN: 01051873     EISSN: 16000536     Source Type: Journal    
DOI: 10.1111/j.1600-0536.2012.02130.x     Document Type: Review

References (21)

1. Irvine A D, McLean W H I, Leung D Y M., Filaggrin mutations associated with skin and allergic diseases. N Engl J Med 2011: 365: 1315-1327.
2. Thyssen J P, Carlsen B C, Menné T, et al., Filaggrin null mutations increase the risk and persistence of hand eczema in subjects with atopic dermatitis: results from a general population study. Br J Dermatol 2010: 163: 115-120.
3. Gruber R, Elias P M, Crumrine D, et al., Filaggrin genotype in ichthyosis vulgaris predicts abnormalities in epidermal structure and function. Am J Pathol 2011: 178: 2252-2263.
4. Scharschmidt T C, Man M Q, Hatano Y, et al., Filaggrin deficiency confers a paracellular barrier abnormality that reduces inflammatory thresholds to irritants and haptens. J Allergy Clin Immunol 2009: 124: 496-506.
5. Flohr C, England K, Radulovic S, et al., Filaggrin loss-of-function mutations are associated with early-onset eczema, eczema severity and transepidermal water loss at 3 months of age. Br J Dermatol 2010: 163: 1333-1336.
6. Thyssen J P, Carlsen B C, Johansen J D, et al., Filaggrin null-mutations may be associated with a distinct subtype of atopic hand eczema. Acta Derm Venereol 2010: 90: 528.
7. Lerbaek A, Bisgaard H, Agner T, Ohm K K, Palmer C N, Menné T., Filaggrin null alleles are not associated with hand eczema or contact allergy. Br J Dermatol 2007: 157: 1199-1204. (Pubitemid 350115708)
8. Thyssen J P, Carlsen B C, Johansen J D, et al., Filaggrin haploinsufficiency among patients with dermatitis from a tertiary referral centre: early findings and possible phenotype. Contact Dermatitis 2010: 62: 182-183.
9. Nexmand P., Clinical Studies of Besnier's Prurigo, Denmark, University of Copenhagen, Copenhagen, 1948.
10. Simpson E L, Thompson M M, Hanifin J M., Prevalence and morphology of hand eczema in patients with atopic dermatitis. Dermatitis 2006: 17: 123-127. (Pubitemid 44786776)
11. Menné T, Johansen J D, Sommerlund M, Veien N K., Hand eczema guidelines based on the Danish guidelines for the diagnosis and treatment of hand eczema. Contact Dermatitis 2011: 65: 3-12.
12. Johansen J D, Hald M, Andersen B L, et al., Classification of hand eczema: clinical and aetiological types. Based on the guideline of the Danish. Contact Dermatitis Group. Contact Dermatitis 2011: 65: 13-21.
13. Veien N, Menné T., Acute and recurrent vesicular hand dermatitis (pompholyx). In: Hand Eczema, Menné T, Maibach H I, (eds): Boca Raton, FL, CRC, 2000: pp. 147-164.
14. Thyssen J P, Ross-Hansen K, Johansen J D, et al., Filaggrin loss-of-function mutation R501X and 2282del4 carrier status is associated with fissured skin on the hands: results from a cross-sectional population study. Br J Dermatol 2011: 166: 46-53.
15. Thyssen J P, Menné T, Zachariae C., Minervar. BMJ 2012: 344: e2441; DOI: 10.1136/bmj.e2441 (Published 4 April 2012).
16. Fahy C M R, McLean W H I, Irvine A D., Variation in the development of phenotype in filaggrin-deficiency: a murine model of atopic dermatitis. In: Poster at British Association of Dermatologists Annual Meeting, Manchester, 2011.
17. Scott I R, Harding C R., Filaggrin breakdown to water binding compounds during development of the rat stratum corneum is controlled by the water activity of the environment. Dev Biol 1986: 115: 84-92. (Pubitemid 16118872)
18. Howell M D, Kim B E, Gao P, et al., Cytokine modulation of atopic dermatitis filaggrin skin expression. J Allergy Clin Immunol 2009: 124 (3 Suppl. 2): R7-R12.
19. Paller A S, van Steensel M A, Rodriguez-Martin M, et al., Pathogenesis-based therapy reverses cutaneous abnormalities in an inherited disorder of distal cholesterol metabolism. J Invest Dermatol 2011: 131: 2242-2248.
20. Brown S J, Relton C L, Liao H, et al., Filaggrin haploinsufficiency is highly penetrant and is associated with increased severity of eczema: further delineation of the skin phenotype in a prospective epidemiological study of 792 school children. Br J Dermatol 2009: 161: 884-889.
21. Kao J S, Fluhr J W, Man M Q, et al., Short-term glucocorticoid treatment compromises both permeability barrier homeostasis and stratum corneum integrity: inhibition of epidermal lipid synthesis accounts for functional abnormalities. J Invest Dermatol 2003: 120: 456-464. (Pubitemid 36298433)